Bafna Pharmaceuticals (NSE:BAFNAPH) Days Sales Outstanding : 127.78 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Bafna Pharmaceuticals Days Sales Outstanding?

Bafna Pharmaceuticals's average Accounts Receivable for the three months ended in Dec. 2023 was ₹398 Mil. Bafna Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was ₹284 Mil. Hence, Bafna Pharmaceuticals's Days Sales Outstanding for the three months ended in Dec. 2023 was 127.78.

The historical rank and industry rank for Bafna Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

NSE:BAFNAPH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.96 Med: 195.85 Max: 347.9
Current: 80.95

During the past 13 years, Bafna Pharmaceuticals's highest Days Sales Outstanding was 347.90. The lowest was 39.96. And the median was 195.85.

NSE:BAFNAPH's Days Sales Outstanding is ranked worse than
58.94% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs NSE:BAFNAPH: 80.95

Bafna Pharmaceuticals's Days Sales Outstanding increased from Dec. 2022 (56.09) to Dec. 2023 (127.78).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Bafna Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Bafna Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bafna Pharmaceuticals Days Sales Outstanding Chart

Bafna Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

205.45

132.64

39.96

52.17

88.49

Bafna Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															56.09	88.88	89.51	89.34	127.78

Competitive Comparison of Bafna Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Bafna Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bafna Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bafna Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Bafna Pharmaceuticals's Days Sales Outstanding falls into.

Bafna Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Bafna Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (147.796	+	411.485)	/	2 )	/	1153.499	*	365
=	279.6405					/	1153.499	*	365
=	88.49

Bafna Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (398.286	+	0)	/	1 )	/	284.422	*	365 / 4
=	398.286					/	284.422	*	365 / 4
=	127.78

Bafna Pharmaceuticals (NSE:BAFNAPH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Bafna Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Bafna Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Bafna Pharmaceuticals (NSE:BAFNAPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bafna Pharmaceuticals Ltd (NSE:BAFNAPH) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

532989:India

Address

Thambu Chetty Street, New No. 68, Old No.299, Bafna Towers, Chennai, TN, IND, 600001

Website

http://www.bafnapharma.com

Bafna Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in the manufacturing and marketing of drugs and medicines. The company sells its products in India and international regions. The company has only one Segment of Business namely Pharmaceuticals.

Bafna Pharmaceuticals (NSE:BAFNAPH) Headlines

No Headlines